Kestra Medical Technologies Ltd
Kestra Medical Technologies Ltd (KMTS) is listed on NASDAQ and classified in Medical Instruments & Supplies, part of the Healthcare sector. It is headquartered in Kirkland, United States and has 443 employees. The company is worth $1.62B. Revenue was $95.13M in fiscal 2026, up 59.0% from the year before. It reported a net loss of $131.61M. The share price is 9.2% below its 52-week high of $30.00. None of the 38 superinvestors we track reported it in their latest 13F. Over the last 30 days, company insiders sold $97.5K of its stock on the open market and bought none.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Year by year, from the annual reports; dividends from the payments themselves.
Bars are year-end balances; lines are what happened during the year.
Major managers that reported this stock in their latest 13F.
None of the investors we track reported a position in KMTS.
▲ +9.3% over 5Y.
This stock has less than 5 years of price history — the answer would measure a shorter period than the one asked for.
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 2 closed years, each at that year’s closing price and reported numbers.
| Indicator | Median | 2026 | 2025 |
|---|---|---|---|
| Year-end price | $27.24 | $26.52 | |
| P/S | — | 16.8x | 22.8x |
| P/B | — | 6.1x | 6.6x |
| EPS | -$2.43 | -$5.13 | |
| Profit margin | — | -138.36% | -190.28% |
| ROE | — | -50.69% | -55.41% |
Median of the years shown; P/E years above 200x are left out.
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| ZBIOZenas BioPharma, Inc. | $24.84 | — | 6.4x | 0.00% | -199.04% | $1.62B |
| PAHCPhibro Animal Health Corp | $39.81 | 16.4x | 4.2x | 1.21% | 29.72% | $1.62B |
| CMPSCOMPASS Pathways plc | $11.63 | — | 18.7x | 0.00% | -319.07% | $1.61B |
| QUREuniQure N.V. | $23.11 |
| — |
| 4.9x |
| 0.00% |
| -157.61% |
| $1.6B |
| NVAXNovavax Inc | $9.99 | — | — | 0.00% | — | $1.65B |
| NUVBNuvation Bio Inc. | $4.70 | — | 6.5x | 0.00% | -47.81% | $1.65B |